54 related articles for article (PubMed ID: 36156374)
1. Generation and characterization of patient-derived xenografts from patients with osteosarcoma.
Chen F; Zhang Z; Shen R; Chen M; Li G; Zhu X
Tissue Cell; 2022 Dec; 79():101911. PubMed ID: 36156374
[TBL] [Abstract][Full Text] [Related]
2. Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach.
Schott CR; Koehne AL; Sayles LC; Young EP; Luck C; Yu K; Lee AG; Breese MR; Leung SG; Xu H; Shah AT; Liu HY; Spillinger A; Behroozfard IH; Marini KD; Dinh PT; Pons Ventura MV; Vanderboon EN; Hazard FK; Cho SJ; Avedian RS; Mohler DG; Zimel M; Wustrack R; Curtis C; Sirota M; Sweet-Cordero EA
Clin Cancer Res; 2024 Feb; 30(4):849-864. PubMed ID: 37703185
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas.
Castillo-Ecija H; Pascual-Pasto G; Perez-Jaume S; Resa-Pares C; Vila-Ubach M; Monterrubio C; Jimenez-Cabaco A; Baulenas-Farres M; Muñoz-Aznar O; Salvador N; Cuadrado-Vilanova M; Olaciregui NG; Balaguer-Lluna L; Burgueño V; Vicario FJ; Manzanares A; Castañeda A; Santa-Maria V; Cruz O; Celis V; Morales La Madrid A; Garraus M; Gorostegui M; Vancells M; Carrasco R; Krauel L; Torner F; Suñol M; Lavarino C; Mora J; Carcaboso AM
J Pathol Clin Res; 2021 Jul; 7(4):338-349. PubMed ID: 33837665
[TBL] [Abstract][Full Text] [Related]
5. Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues.
Sun X; Chang J; Zhou C; Zhao P; Guo S; Tong J; Wang Y; Yang Y
J Vis Exp; 2024 Mar; (205):. PubMed ID: 38587398
[TBL] [Abstract][Full Text] [Related]
6. Development and Expansion of Patient-Derived Xenografts for Endometrial Cancer.
Sengal AT; Pollock PM
Methods Mol Biol; 2024; 2806():101-115. PubMed ID: 38676799
[TBL] [Abstract][Full Text] [Related]
7. Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts).
Hernández Guerrero T; Baños N; Del Puerto Nevado L; Mahillo-Fernandez I; Doger De-Speville B; Calvo E; Wick M; García-Foncillas J; Moreno V
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001663
[No Abstract] [Full Text] [Related]
8. Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors.
Pandya PH; Jannu AJ; Bijangi-Vishehsaraei K; Dobrota E; Bailey BJ; Barghi F; Shannon HE; Riyahi N; Damayanti NP; Young C; Malko R; Justice R; Albright E; Sandusky GE; Wurtz LD; Collier CD; Marshall MS; Gallagher RI; Wulfkuhle JD; Petricoin EF; Coy K; Trowbridge M; Sinn AL; Renbarger JL; Ferguson MJ; Huang K; Zhang J; Saadatzadeh MR; Pollok KE
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612255
[TBL] [Abstract][Full Text] [Related]
9. Consistency between Primary Uterine Corpus Malignancies and Their Corresponding Patient-Derived Xenograft Models.
Ueda S; Tanaka T; Hirosuna K; Miyamoto S; Murakami H; Nishie R; Tsuchihashi H; Toji A; Morita N; Hashida S; Daimon A; Terada S; Maruoka H; Kogata Y; Taniguchi K; Komura K; Ohmichi M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338763
[TBL] [Abstract][Full Text] [Related]
10. Cancer "Avatars": Patient-Derived Xenograft Growth Correlation with Postoperative Recurrence and Survival in Pancreaticobiliary Cancer.
Lynch IT; Abdelrahman AM; Alva-Ruiz R; Fogliati A; Graham RP; Smoot R; Truty MJ
J Am Coll Surg; 2023 Sep; 237(3):483-500. PubMed ID: 37326316
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs).
Patel KR; Espinoza AF; Urbicain M; Patel RH; Major A; Sarabia SF; Lopez-Terrada D; Vasudevan SA; Woodfield SE
Pathol Res Pract; 2024 Mar; 255():155163. PubMed ID: 38394806
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of new patient-derived xenograft (PDX) models of osteosarcoma with distinct metastatic capacities.
Schott CR; Koehne AL; Sayles LC; Young EP; Luck C; Yu K; Lee AG; Breese MR; Leung SG; Xu H; Shah AT; Liu HY; Spillinger A; Behroozfard IH; Marini KD; Dinh PT; Pons Ventura MAV; Vanderboon EN; Hazard FK; Cho SJ; Avedian RS; Mohler DG; Zimel M; Wustrack R; Curtis C; Sirota M; Sweet-Cordero EA
bioRxiv; 2023 Jan; ():. PubMed ID: 36711882
[TBL] [Abstract][Full Text] [Related]
13. A 3D Osteosarcoma Model with Bone-Mimicking Cues Reveals a Critical Role of Bone Mineral and Informs Drug Discovery.
González Díaz EC; Lee AG; Sayles LC; Feria C; Sweet-Cordero EA; Yang F
Adv Healthc Mater; 2022 Sep; 11(17):e2200768. PubMed ID: 35767377
[TBL] [Abstract][Full Text] [Related]
14. Patient-Derived Xenograft Models in Cancer Research: Methodology, Applications, and Future Prospects.
Aslani S; Saad MI
Methods Mol Biol; 2024; 2806():9-18. PubMed ID: 38676792
[TBL] [Abstract][Full Text] [Related]
15. Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study.
Nemati F; de Koning L; Gentien D; Assayag F; Henry E; Ait Rais K; Pierron G; Mariani O; Nijnikoff M; Champenois G; Nicolas A; Meseure D; Gardrat S; Servant N; Hupé P; Kamal M; Le Tourneau C; Piperno-Neumann S; Rodrigues M; Roman-Roman S; Decaudin D; Mariani P; Cassoux N
Curr Oncol; 2023 Oct; 30(10):9090-9103. PubMed ID: 37887557
[TBL] [Abstract][Full Text] [Related]
16. Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer.
He F; Bandyopadhyay AM; Klesse LJ; Rogojina A; Chun SH; Butler E; Hartshorne T; Holland T; Garcia D; Weldon K; Prado LP; Langevin AM; Grimes AC; Sugalski A; Shah S; Assanasen C; Lai Z; Zou Y; Kurmashev D; Xu L; Xie Y; Chen Y; Wang X; Tomlinson GE; Skapek SX; Houghton PJ; Kurmasheva RT; Zheng S
Nat Commun; 2023 Nov; 14(1):7600. PubMed ID: 37990009
[TBL] [Abstract][Full Text] [Related]
17. Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts.
Cassidy JW; Caldas C; Bruna A
Cancer Res; 2015 Aug; 75(15):2963-8. PubMed ID: 26180079
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with engraftment success of patient-derived xenografts of breast cancer.
Lee J; Lee G; Park HS; Jeong BK; Gong G; Jeong JH; Lee HJ
Breast Cancer Res; 2024 Mar; 26(1):49. PubMed ID: 38515107
[TBL] [Abstract][Full Text] [Related]
19. Patient-Derived Xenografts: Historical Evolution, Immunocompromised Host Models, and Translational Significance.
Thompson J; Saad MI
Methods Mol Biol; 2024; 2806():1-8. PubMed ID: 38676791
[TBL] [Abstract][Full Text] [Related]
20. The future of patient-derived xenografts in prostate cancer research.
Lawrence MG; Taylor RA; Cuffe GB; Ang LS; Clark AK; Goode DL; Porter LH; Le Magnen C; Navone NM; Schalken JA; Wang Y; van Weerden WM; Corey E; Isaacs JT; Nelson PS; Risbridger GP
Nat Rev Urol; 2023 Jun; 20(6):371-384. PubMed ID: 36650259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]